Daigo Miyazaki^1,2, Mitsuto Sato^1,5, Naoko Shiba³, Takahiro Yoshizawa⁴, Akinori Nakamura^1,6 (1.Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan, 2.Shinshu Medical Care Collaboration Center (Division of Support for Intractable Disease), Shinshu University Hospital, Japan, 3.Institute for Biomedical Sciences, Shinshu University, Japan, 4.Research Center for Supports to Advanced Science, Shinshu University, Japan, 5.Department of Brain Disease Research, Shinshu University School of Medicine, Japan, 6.Department of Clinical Research, National Hospital Organization Matsumoto Medical Center, Japan)

Katsuhiko Kunitake¹, Tomomi Yoshida-hashidate², Hideo Shindou^2,3, Yoshitsugu Aoki¹ (1.Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan, 2.Department of Lipid Signaling, Research Institute, National Center for Global Health and Medicine (NCGM), Japan, 3.Department of Medical Lipid Science, Graduate School of Medicine, The University of Tokyo, Japan)

Yutaka Ohsawa, Yoshihide Sunada (Neurology, Kawasaki Medical School, Japan)

Satoshi Yamashita^1,2, Yuji Takahashi³, Jun Hashimoto⁴, Masahisa Katsuno⁵, Masashi Aoki⁶ (1.International University of Health and Welfare Narita Hospital, Japan, 2.Kumamoto University Graduate School of Medical Sciences, Japan, 3.National Center of Neurology and Psychiatry, Japan, 4.National Hospital Organization Osaka Minami Medical Center, Japan, 5.Nagoya University Graduate School of Medicine, Japan, 6.Tohoku University Graduate School of Medicine, Japan)